Trial Profile
A multicenter phase II trial of Recipient pre-treatment with Short-Term Rapamycin for the prevention of acute GVHD after haematopoietic stem cell transplantation in Elderly Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2014
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 02 Jul 2014 New trial record